论文部分内容阅读
目的:研究分析化疗患者应用血管通路优选法的临床疗效。方法:选取180例化疗患者,均为首次进行化疗治疗,将其平均分为对照组和观察组各90例。给予对照组患者实施传统的静脉治疗措施,给予观察组患者实施血管通路优选法的治疗措施,对两组患者治疗后的满意度、静脉炎发生率和组织渗漏性损伤率进行对比。结果:观察组患者在治疗后满意度、静脉炎及组织渗漏性损伤的发生率方面均明显优于对照组患者。两组患者在以上方面差异具有统计学意义(P<0.05)。结论:在化疗患者的临床治疗中,应用血管通道优选法的治疗措施可以有效降低静脉炎及组织渗漏性损伤等恶性事件的发生,提升治疗满意度,降低患者的治疗痛苦,有效改善患者的生活质量。
OBJECTIVE: To study the clinical efficacy of optimal vascular access in patients undergoing chemotherapy. Methods: 180 cases of chemotherapy patients were selected, were the first chemotherapy, the average divided into control group and observation group of 90 cases. The patients in the control group were treated with traditional venous therapy and the patients in the observation group were treated with the optimal method of vascular access. The satisfaction, the incidence of phlebitis and the rate of tissue leakage injury were compared between the two groups after treatment. Results: The patients in the observation group were significantly better than those in the control group in terms of satisfaction after treatment, phlebitis and the incidence of tissue leakage injury. Two groups of patients in the above differences were statistically significant (P <0.05). Conclusion: In the clinical treatment of patients with chemotherapy, the treatment of vascular access preferred method can effectively reduce the incidence of phlebitis and tissue leakage injury and other malignant events, improve the satisfaction of treatment, reduce the patient’s pain and effectively improve the life of the patient quality.